Neural progenitor cell-mediated delivery of interferon beta improves neuroblastoma response to cyclophosphamide

Annals of Surgical Oncology

Volumn 15, Issue 11, 2008, Pages 3259-3267

  Sims Jr , Thomas L ^a,b   Hamner, John B ^a,b   Bush, Rebecca A ^b   Williams, Regan F ^a,b   Zhou, Junfang ^b   Kim, Seung U ^c,d   Aboody, Karen S ^e   Danks, Mary K ^b   Davidoff, Andrew M ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c Gachon University College of Medicine   (South Korea)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA INTERFERON; CYCLOPHOSPHAMIDE; LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOLUMINESCENCE; CD34 SELECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; MALE; MOUSE; NEURAL STEM CELL; NEUROBLASTOMA; NICK END LABELING; NONHUMAN; PERICYTE; TUMOR CELL; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VASCULARIZATION; TUMOR VOLUME;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTIVIRAL AGENTS; CELLS, CULTURED; CYCLOPHOSPHAMIDE; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; GENE THERAPY; GENETIC VECTORS; HUMANS; INJECTIONS, INTRAVENOUS; INTERFERON-BETA; MALE; MICE; MICE, SCID; NEUROBLASTOMA; NEURONS; STEM CELLS; TUMOR BURDEN;

EID: 55149106765     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0103-z     Document Type: Article

References (33)

1. RW Miller JL Young Jr B Novakovic 1995 Childhood cancer Cancer 75 1 Suppl 395 405
2. KK Matthay JG Villablanca RC Seeger 1999 Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group N Engl J Med 341 1165 73
3. CJ Streck CY Ng Y Zhang 2005 Interferon-mediated anti-angiogenic therapy for neuroblastoma Cancer Lett 228 163 70
4. CJ Streck Y Zhang R Miyamoto 2004 Restriction of neuroblastoma angiogenesis and growth by interferon-alpha/beta Surgery 136 183 9
5. MB McCarville CJ Streck PV Dickson 2006 Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US Radiology 240 73 81
6. AW Le Serve K Hellmann 1972 Metastases and the normalization of tumour blood vessels by ICRF 159: a new type of drug action Br Med J 1 597 601
7. BA Teicher SA Holden G Ara 1994 Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents Int J Cancer 57 920 5
8. RK Jain 2001 Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy Nat Med 7 987 9
9. PV Dickson JB Hamner CJ Streck 2007 Continuous delivery of IFN-beta promotes sustained maturation of intratumoral vasculature Mol Cancer Res 5 531 42
10. PV Dickson JB Hamner TL Sims 2007 Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy Clin Cancer Res 13 3942 50
11. PV Dickson NL Hagedorn JB Hamner 2007 Interferon-β mediated improved efficacy of systemically administered topotecan in a murine neuroblastoma model J Pediatr Surg 42 160 5
12. S Einhorn D Grander 2006 Why do so many cancer patients fail to respond to interferon therapy? J Interferon Cytokine Res 16 275 81
13. P Salmon JY Le Cotonnec A Galazka 1996 Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers J Interferon Cytokine Res 16 759 64
14. S Bendetti B Pirola B Pollo 2000 Gene therapy of experimental brain tumors using neural progenitor cells Nat Med 6 447 50
15. KS Aboody J Najbauer NO Schmidt 2006 Targeting of melanoma brain metastases using engineered neural stem/progenitor cells Neuro Oncol 8 119 26
16. A Brown W Yang N Schmidt 2003 Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin Hum Gene Ther 14 1777 85
17. K Aboody A Brown N Rainov 2000 Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas Proc Natl Acad Sci USA 97 12846 51
18. MK Danks KJ Yoon R Bush 2007 Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma Cancer Res 67 22 5
19. PV Dickson JB Hamner R Burger 2007 Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-β and restricts tumor growth in a murine model of disseminated neuroblastoma J Pediatr Surg 42 48 53
20. S Kim E Nakagawa K Hatori 2002 Production of immortalized human neural crest stem cells Methods Mol Biol 198 55 65
21. PV Dickson B Hamner CY Ng 2007 In vivo bioluminescence imaging for early detection and monitoring of disease progression in a murine model of neuroblastoma J Pediatr Surg 42 1172 9
22. DS Ory BA Neugeboren RC Mulligan 1996 A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes Proc Natl Acad Sci USA 93 11400 6
23. WW Spurbeck CY Ng TS Strom 2002 Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model Blood 100 3361 8
24. RT Tong Y Boucher SV Kozin 2004 Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors Cancer Res 64 3731 6
25. C Lo C Liu S Chan 2007 A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma Ann Surg 24 831 42
26. S Moschos J Kirkwood 2007 Present role and future potential of type I interferons in adjuvant therapy of high-risk operable melanoma Cytokine Growth Factor Rev 18 451 8
27. T Wakabayashi A Natsume Y Hashizume 2008 A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy J Gene Med 10 329 39
28. T Tanabe S Kominsky P Subramaniam 2000 Inhibition of the glioblastoma cell cycle by type I IFNs occurs at both the G1 and S phases and correlates with the upregulation of P21 (WAF1/CIP1) J Neurooncol 48 225 32
29. JM Kirkwood T Richards H Zarour 2002 Immunomodulatory effects of high-dose and low-does interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of Intergroup Adjuvant Trial E1690 Cancer 95 1101 12
30. Q Chen B Gong A Mahmoud-Ahmed 2001 Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma Blood 98 2183 92
31. JW Slaton P Perrotte K Inoue 1999 Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule Clin Cancer Res 5 2726 34
32. J Hori TF Ng M Shatos 2003 Neural progenitor cells lack immunogenicity and resist destruction as allografts Stem Cells 21 405 16
33. J Odeberg JH Piao EB Samuelsson 2005 Low immunogenicity of in vitro-expanded human neural cells despite high MHC expression J Neuroimmunol 161 1 11